- Home
- VNOM vs CRNX Comparison
VNOM vs CRNX Comparison
Compare VNOM & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNOM
- CRNX
- Stock Information
- Founded
- VNOM 2013
- CRNX 2008
- Country
- VNOM United States
- CRNX United States
- Employees
- VNOM N/A
- CRNX N/A
- Industry
- VNOM Oil & Gas Production
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- VNOM Energy
- CRNX Health Care
- Exchange
- VNOM Nasdaq
- CRNX Nasdaq
- Market Cap
- VNOM 5.3B
- CRNX 5.2B
- IPO Year
- VNOM 2014
- CRNX 2018
- Fundamental
- Price
- VNOM $45.15
- CRNX $33.54
- Analyst Decision
- VNOM Strong Buy
- CRNX Strong Buy
- Analyst Count
- VNOM 13
- CRNX 12
- Target Price
- VNOM $58.62
- CRNX $73.36
- AVG Volume (30 Days)
- VNOM 1.5M
- CRNX 928.6K
- Earning Date
- VNOM 05-05-2025
- CRNX 05-08-2025
- Dividend Yield
- VNOM 5.52%
- CRNX N/A
- EPS Growth
- VNOM 42.01
- CRNX N/A
- EPS
- VNOM 3.82
- CRNX N/A
- Revenue
- VNOM $817,200,000.00
- CRNX $1,039,000.00
- Revenue This Year
- VNOM $57.37
- CRNX $394.51
- Revenue Next Year
- VNOM $18.90
- CRNX $699.82
- P/E Ratio
- VNOM $11.82
- CRNX N/A
- Revenue Growth
- VNOM 3.34
- CRNX N/A
- 52 Week Low
- VNOM $35.46
- CRNX $31.65
- 52 Week High
- VNOM $56.76
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- VNOM 50.95
- CRNX 41.58
- Support Level
- VNOM $43.36
- CRNX $32.90
- Resistance Level
- VNOM $46.32
- CRNX $35.26
- Average True Range (ATR)
- VNOM 1.30
- CRNX 1.51
- MACD
- VNOM 0.35
- CRNX 0.15
- Stochastic Oscillator
- VNOM 78.37
- CRNX 39.38
About VNOM Viper Energy Inc.
Viper Energy Inc is focused on owning and acquiring mineral and royalty interests in oil and natural gas properties primarily in the Permian Basin. The Permian Basin is known to have a number of zones of oil and natural gas-bearing rock throughout.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.